Corneal Edema Epidemiology Forecast 2026-2035

Corneal edema is characterized by excessive hydration of the corneal stroma, impairing transparency and visual acuity, and may result from surgical, dystrophic, or inflammatory causes. According to Celeste Briceno-Lopez et al., 2023, it is the most common complication of ocular surgery, with reported prevalence ranging from 6.2% to 11.3%. As per the corneal edema epidemiology forecast, the number of diagnosed cases is increasing globally, with sustained growth projected through forecast period.

Corneal Edema Epidemiology Forecast Report Coverage

The analyst's “Corneal Edema Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of corneal edema. It projects the future incidence and prevalence rates of corneal edema cases across various populations. The study covers age, gender, and type as major determinants of the corneal edema population. The report highlights patterns in the prevalence of corneal edema over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of corneal edema in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Corneal Edema Understanding: Disease Overview

Corneal edema is a condition characterized by swelling of the cornea due to the accumulation of excess fluid within its layers, leading to impaired transparency and blurred vision. It occurs when the corneal endothelium, responsible for maintaining fluid balance, becomes damaged or dysfunctional. Common causes include ocular surgery, trauma, infection, inflammation, and endothelial disorders such as Fuchs’ endothelial dystrophy. The condition may be classified as epithelial, stromal, or endothelial corneal edema, depending on the affected layer. Symptoms often include halos around lights, eye discomfort, reduced visual acuity, and increased light sensitivity.

Corneal Edema Epidemiology Perspective

The corneal edema epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the corneal edema epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for corneal edema and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Julia Bonavitacola et al., 2025, glaucoma drainage devices showed a higher incidence of corneal edema at 27.7% compared with 13.5% following trabeculectomy, over a mean follow-up of 4.7 years among 333 eyes from 245 patients, with an average surgical age of 73.9 years.
• Glaucoma drainage devices increased corneal edema risk threefold (hazard ratio 3.07; 95% confidence interval 1.02-9.17), and each additional glaucoma surgery doubled the risk (hazard ratio 2.40), with edema developing after a mean of 6.2 years postoperatively.
• According to the American Academy of Ophthalmology, the incidence of acute corneal hydrops in keratoconus ranges from 0.2% to 2.8%, most commonly affecting individuals aged 20-40 years, with males experiencing up to twice the risk compared with females.
• As per regional data cited by the American Academy of Ophthalmology, higher prevalence rates of keratoconus and acute corneal hydrops were observed among Pacific Island populations in New Zealand and among South Asian and Black patients in the United Kingdom.
• According to Yuan Kai Fu et al., 2024, the estimated incidence of argon laser iridotomy-induced corneal edema was 1.8%, contributing to up to 20% of corneal transplantation etiologies in Japan, with onset typically occurring 5.5-7.4 years after the procedure.

Country-wise Corneal Edema Epidemiology

The corneal edema epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Across major developed and emerging markets, corneal edema represents a significant contributor to the overall burden of corneal disorders. According to Lynda Seminara et al., 2025, in the United States, 5,220,382 patients were diagnosed with corneal opacity or scar, with a case frequency of 6,535 per 100,000 visits (6.5%), and corneal edema accounted for 18.3% of identified causes. As per Jun Shimazaki et al., 2025, in Japan, corneal edema was the leading indication for corneal transplantation, representing 39.3% of 4,951 cases. Comparable surgical trends and aging populations suggest a meaningful epidemiological burden.

Corneal Edema: Treatment Overview

Corneal edema treatment depends on its severity and underlying cause. Mild cases may be managed with hypertonic saline eye drops or ointments to reduce fluid accumulation and improve corneal clarity. Topical corticosteroids may be prescribed when inflammation contributes to the condition. In cases associated with elevated intraocular pressure, pressure-lowering medications are utilized. Advanced or persistent corneal edema may require surgical intervention, including endothelial keratoplasty or penetrating keratoplasty, to restore corneal function and visual acuity. Prompt diagnosis and management are essential to prevent permanent visual impairment.

Key Questions Answered

• What are the key findings of corneal edema epidemiology in the 8 major markets?
• What will be the total number of patients with corneal edema across the 8 major markets during the forecast period?
• What was the country-wise corneal edema epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of corneal edema patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of corneal edema during the forecast period of 2026-2035?
• What are the currently available treatments for corneal edema?
• What are the disease risks, signs, symptoms, and unmet needs of corneal edema?

Scope of the Corneal Edema Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of corneal edema based on several factors.
• Corneal Edema Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The corneal edema report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.